Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D002994:Clofibrate / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects*; D006016:Glycolates / Q000494:pharmacology; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008830:Microbodies / Q000187:drug effects*; D008862:Microsomes, Liver / Q000378:metabolism; D009153:Mutagens; D009255:Nafenopin / Q000494:pharmacology; D009940:Organoids / Q000187:drug effects*; D010880:Piperidines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D012486:Salmonella typhimurium / Q000187:drug effects; D013853:Thioacetamide / Q000031:analogs & derivatives / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism
D000085:Acetates; D006016:Glycolates; D000960:Hypolipidemic Agents; D009153:Mutagens; D010880:Piperidines; D011743:Pyrimidines; D013853:Thioacetamide; D009255:Nafenopin; D003208:Concanavalin A; D002994:Clofibrate; D013936:Thymidine